- Report
- October 2024
- 187 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 195 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- May 2024
- 131 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- January 2025
- 207 Pages
Global
From €4546EUR$4,995USD£3,897GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1138EUR$1,250USD£975GBP
- Report
- February 2024
- 135 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- February 2023
- 83 Pages
Asia Pacific
From €1365EUR$1,500USD£1,170GBP
- Report
- January 2024
- 93 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- January 2024
- 95 Pages
United States
€3185EUR$3,500USD£2,731GBP
- Report
- January 2024
- 89 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- November 2021
- 600 Pages
Global
From €3640EUR$4,000USD£3,121GBP

Sumatriptan is a drug used to treat migraine headaches. It is a member of the triptan class of drugs, which are serotonin receptor agonists. Sumatriptan works by narrowing the blood vessels around the brain, reducing inflammation and relieving pain. It is available in both oral and injectable forms, and is often used in combination with other medications.
Sumatriptan is a popular drug in the Central Nervous System (CNS) drug market. It is used to treat a variety of conditions, including migraine headaches, cluster headaches, and tension headaches. It is also used to treat other conditions such as fibromyalgia and chronic pain. Sumatriptan is generally well-tolerated and has few side effects.
Some companies in the Sumatriptan market include GlaxoSmithKline, Pfizer, Merck, and Novartis. Show Less Read more